sasha@extima.com - CurvaFix

sasha@extima.com

CurvaFix to Host Industry Session at Orthopaedic Trauma Association Annual Meeting; Technology Featured in Poster Presentation

CurvaFix to Host Industry Session at Orthopaedic Trauma Association Annual Meeting; Technology Featured in Poster Presentation Session to highlight how surgeons are using CurvaFix IM Implant for complex pelvic morphology, periprosthetic fracture, and Fragility Fractures of the Pelvis  BELLEVUE, Wash., Oct. 18, 2023 – CurvaFix, Inc., a developer of medical devices that delivers stable fixation […]

CurvaFix to Host Industry Session at Orthopaedic Trauma Association Annual Meeting; Technology Featured in Poster Presentation Read More »

CurvaFix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly

CurvaFix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly CurvaFix® IM Implant delivers robust, stable pelvic fracture fixation even in weakened bones  BELLEVUE, Wash., Oct. 5, 2023 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, announced today it will showcase the CurvaFix® IM Implants for

CurvaFix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly Read More »

Artboard 1

Inserting a Curve into the Treatment of Fragility Fractures of the Pelvis (FFP)

As we age, our bone density decreases, creating greater risk of fractures of the pelvis. Women especially are at increased risk of fractures due to hormonal changes experienced during menopause that directly affect bone density and strength. Men in their 70s experience a similar weakening of their bones due to the loss of testosterone, affecting bone density.

Inserting a Curve into the Treatment of Fragility Fractures of the Pelvis (FFP) Read More »

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition BELLEVUE, Wash., July 14, 2023 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of a $39 million equity financing led by MVM Partners with participation from Sectoral Asset Management

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition Read More »

CurvaFix

CurvaFix Launches Smaller-diameter CurvaFix® IM Implant

CurvaFix Launches Smaller-diameter CurvaFix® IM Implant Novel 7.5mm curved device will be showcased at the upcoming AAOS 2023 BELLEVUE, Wash., February 16, 2023 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the launch of its smaller-diameter, 7.5mm CurvaFix® IM Implant, designed to simplify surgery and provide strong,

CurvaFix Launches Smaller-diameter CurvaFix® IM Implant Read More »

CurvaFix

New FDA Clearance for CurvaFix Intramedullary Implant

New FDA Clearance for CurvaFix Intramedullary Implant FULL ARTICLE Used with permission of ORTHOWORLD, Inc. by Julie A. Vetalice CurvaFix received FDA 510(k) clearance to market a smaller-diameter CurvaFix® Intramedullary Implant indicated for fixation of fractures of the pelvis. The new 7.5mm device is designed to provide strong, stable, curved fixation in smaller patients. Clinical

New FDA Clearance for CurvaFix Intramedullary Implant Read More »

CurvaFix

CurvaFix Receives FDA Clearance for Smaller-diameter, Intramedullary Implant for Pelvic Fracture Fixation

CurvaFix Receives FDA Clearance for Smaller-diameter, Intramedullary Implant for Pelvic Fracture Fixation DOWNLOAD FULL PRESS RELEASE BELLEVUE, Wash., Nov. 1, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced it has received 510(k) clearance (K222505) from the U.S. Food & Drug Administration (FDA) for its smaller-diameter CurvaFix®

CurvaFix Receives FDA Clearance for Smaller-diameter, Intramedullary Implant for Pelvic Fracture Fixation Read More »

CurvaFix

CurvaFix Announces New Surgeon Advisory Board Members

CurvaFix Announces New Surgeon Advisory Board Members Solidifying expertise in high-impact trauma and fragility fractures of the pelvis DOWNLOAD FULL PRESS RELEASE BELLEVUE, Wash., Sept. 28, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the addition of three new members to its Surgeon Advisory Board. The

CurvaFix Announces New Surgeon Advisory Board Members Read More »

CurvaFix

CurvaFix Announces Participation in Orthopaedic Trauma Association Industry Sessions

CurvaFix Announces Participation in Orthopaedic Trauma Association Industry Sessions Educational Session to Highlight Minimally Invasive Surgical Fixation Option for Fragility and High Impact Fractures of the Pelvis DOWNLOAD FULL PRESS RELEASE BELLEVUE, Wash., Oct. 6, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced participation in the

CurvaFix Announces Participation in Orthopaedic Trauma Association Industry Sessions Read More »